Dr. Urmeel Patel


Urmeel Patel, MD

Medical Oncology and Hematology
dr urmeel patel

Locations

Review Us At:

See Dr. Patel's profile on Healthgrades.

About

In 2018, Dr. Urmeel Patel joined Millennium Physicians as one of our Medical Oncologist and Hematologist. He has an interest in treating solid tumor malignancy, lymphoma, myeloma and benign blood disorders. His research endeavors include breast cancer, metastatic bone disease, multiple myeloma and anticoagulation. Most important to Dr. Patel is his relationship with his patients and working as a team to improve his patients’ health and quality of life. He is accepting new patients at our Cypress, Shenandoah and North Houston locations.

Education

College: Bachelor of Science in Biology at Loyola University Chicago - 2006

Medical School: Doctor of Medicine at Ross University School of Medicine - 2012

Residency: Internal Medicine at University of Pittsburgh Medical Center – Pinnacle - 2015

Fellowship: Medical Oncology and Hematology at Penn State Cancer Institute - 2018

Areas of Interests

  • Solid Tumor, Lymphoma, Myeloma and Benign Blood Disorders
  • Bone Marrow Aspirate and Biopsy
  • Evaluation of Peripheral Smear
  • Lumbar Puncture and Intrathecal Chemotherapy Administration

Professional Memberships

  • American Society of Clinical Oncology (ASCO)
  • American Society of Hematology (ASH)
  • Texas Medical Association
  • Harris County Medical Society

Publications

  • Nonsecretory and Light Chain Escape in Patients With Multiple Myeloma. 2018 Clinical Lymphoma, Myeloma and Leukemia
  • Serum PD-L1 and outcomes in CCTG MA.31 phase 3 trial of anti-HER2 therapy in first-line HER2+ metastatic breast cancer patients (trastuzumab arm only). 2018 ASCO Abstract
  • Central Neurotoxicity of Immunomodulatory Drugs in Multiple Myeloma. 2015 Hematology Reports

  • Anticoagulation Clinic Protocol and Electronic Medical Records in Patients Treated with Warfarin: Do They Increase the Likelihood of Achieving Therapeutic INR? 2014 Blood

  • Does Depression Increase Risk for Noncompliance with Warfarin Therapy? 2014 Blood